Replies to post #748 on Bristol Myers Squibb (BMY)

[Johnny_C]

Tiny Deal... Want some big news.... The PFE / Merk lung drug failed...

[Johnny_C]

Very Good deal for NKTR though, and utimately could be great for BMY pipeline.

I doubt a MS upgrade drove the price of BMY the lsat few days

[DewDiligence]

NKTR-214 JV clears HSR review—BMY can now start enrolling patients in multiple pivotal trials of Opdivo + NKTR-214, as previously described:

https://www.prnewswire.com/news-releases/nektar-therapeutics-announces-effective-date-of-global-development--commercialization-collaboration-with-bristol-myers-squibb-300623904.html